TAT-SALL4, and TAT-control (TAT-con) peptides was evaluated by the MTT assay. Data were normalized to the non-treated control, and represent the mean values (± s.d.) of quadruplicate cultures from two independent experiments. SALL4 functional inhibition by TAT-SALL4 peptide significantly reduced cell viability in SALL4 positive lung cancer lines (H661, H522, and PC-9), but not in the SALL4 negative lung cancer line H1299. In contrast, treatment with TAT-con peptide or TAT alone only led to a slight decreased in cell viability in these cell lines. *P < 0.05.
